HJB - Your Trusted Biologics CDMO Partner

HJB, CDMO, biologics, HJB Bio, hjbbio, China CDMO, 杭州奕安济世, Just Bio, Just biotherapeutics, HJB bio, HJB China, Hangzhou HJB

HJB - Your Trusted Biologics CDMO Partner

Cn
Company News

21Apr, 2022

Leveraging HJB’s highly productive continuous perfusion platform, client’s manufacturing process output was increased by > 8 folds and the process change was recently approved by NMPA.

31Mar, 2022

HJB Congratulates its partner BioneCure for receiving IND approval from U.S.FDA for BIO-106

HJB congratulates its partner BioneCure for receiving IND approval for BIO-106.

30Dec, 2021

HJB congratulates its client on an approval of CMC process change supplemental application filed to Chinese National Medical Products Administration (NMPA) in support of a late phase clinical trial in China.

HJB congratulates its client on an approval of CMC process change supplemental application filed to  NMPA in support of a late phase clinical trial in China.

21Aug, 2021

HJB Congratulates Kanova Biopharma on receiving IND approval for XKH001 from U.S.FDA

HJB Congratulates its partner Kanova Biopharma for receiving IND approval from U.S.FDA for XKH001, a humanized monoclonal antibody for the treatment of autoimmune disease.


06Jul, 2021

HJB Congratulates its partner for receiving IND approval from NMPA

HJB congratulates its partner for receiving IND approval from NMPA.

05Jul, 2021

HJB Congratulates Miracogen for receiving IND acceptance for MRG004A from NMPA

HJB Congratulates its partner Miracogen for receiving IND acceptance from NMPA for MRG004A, an tissue factor-targeted antibody–drug conjugate. 

01Jun, 2021

HJB's Automated Drug Product Vial Filling Line Is Ready for Clinical Projects

HJB has installed, commissioned, and validated a new Bosch fully isolated and automated drug product vial filling line and is ready for clinical projects. 

13Apr, 2021

HJB Congratulates its partner for receiving IND approval from U.S.FDA

HJB congratulates its partner for receiving IND approval from FDA.